How brain support cells influence tau-related damage in Alzheimer's

Functional analysis of glia in tauopathy

NIH-funded research Brigham and Women's Hospital · NIH-11297637

Researchers are looking for which brain support cells and genes change how tau protein harms nerve cells in Alzheimer's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11297637 on NIH RePORTER

What this research studies

This project uses powerful genetic tools in fruit flies to study how glia — the brain's support cells — affect tau-related brain damage linked to Alzheimer's. Scientists will turn up or turn down genes, including ones found in human Alzheimer’s genetic studies, and run broad screens to see which changes make tau toxicity better or worse. The team has already shown their fly system can detect non‑cellular effects where glia influence nearby neurons. Findings are meant to point to specific glial pathways that could be studied next in mammals and, eventually, in people.

Who could benefit from this research

Good fit: This project does not enroll people, but patients with Alzheimer's disease or those at risk could be future beneficiaries of therapies developed from these discoveries.

Not a fit: People seeking immediate treatment or clinical enrollment will not benefit directly because the work is laboratory research in flies rather than a patient trial.

Why it matters

Potential benefit: If successful, the work could reveal new glial targets or pathways that lead to treatments or tests to slow or prevent tau-driven neurodegeneration.

How similar studies have performed: Related genetic screens in model organisms have uncovered pathways later studied in mammals, but translating fly findings into human therapies remains challenging.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.